Literature DB >> 29293090

The fibrotic tumor stroma.

Mitsuo Yamauchi1, Thomas H Barker2, Don L Gibbons3,4, Jonathan M Kurie3.   

Abstract

Intratumoral fibrosis results from the deposition of a cross-linked collagen matrix by cancer-associated fibroblasts (CAFs). This type of fibrosis has been shown to exert mechanical forces and create a biochemical milieu that, together, shape intratumoral immunity and influence tumor cell metastatic behavior. In this Review, we present recent evidence that CAFs and tumor cells are regulated by provisional matrix molecules, that metastasis results from a change in the type of stromal collagen cross-link, and that fibrosis and inflammation perpetuate each other through proteolytic and chemotactic mediators released into the tumor stroma. We also discuss aspects of the emerging biology that have potential therapeutic value.

Entities:  

Mesh:

Year:  2018        PMID: 29293090      PMCID: PMC5749516          DOI: 10.1172/JCI93554

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  182 in total

Review 1.  Myofibroblasts and mechano-regulation of connective tissue remodelling.

Authors:  James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

Review 2.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 3.  Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.

Authors:  Padmanee Sharma; James P Allison
Journal:  Cell       Date:  2015-04-09       Impact factor: 41.582

Review 4.  The biology and function of fibroblasts in cancer.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2016-08-23       Impact factor: 60.716

5.  Lung collagen cross-links in rats with experimentally induced pulmonary fibrosis.

Authors:  J E Gerriets; K M Reiser; J A Last
Journal:  Biochim Biophys Acta       Date:  1996-06-07

6.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

7.  Effects of three anti-TNF-alpha drugs: etanercept, infliximab and pirfenidone on release of TNF-alpha in medium and TNF-alpha associated with the cell in vitro.

Authors:  K J Grattendick; J M Nakashima; L Feng; S N Giri; S B Margolin
Journal:  Int Immunopharmacol       Date:  2008-02-11       Impact factor: 4.932

8.  Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy.

Authors:  Fotios Mpekris; Panagiotis Papageorgis; Christiana Polydorou; Chrysovalantis Voutouri; Maria Kalli; Athanassios P Pirentis; Triantafyllos Stylianopoulos
Journal:  J Control Release       Date:  2017-06-27       Impact factor: 9.776

Review 9.  Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles.

Authors:  Hala S Alameddine; Jennifer E Morgan
Journal:  J Neuromuscul Dis       Date:  2016-11-29

10.  Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer.

Authors:  Julienne L Carstens; Pedro Correa de Sampaio; Dalu Yang; Souptik Barua; Huamin Wang; Arvind Rao; James P Allison; Valerie S LeBleu; Raghu Kalluri
Journal:  Nat Commun       Date:  2017-04-27       Impact factor: 14.919

View more
  73 in total

1.  Why Stress Matters: An Introduction.

Authors:  Daniel J Tschumperlin
Journal:  Methods Mol Biol       Date:  2021

2.  Dual-mode emission and transmission microscopy for virtual histochemistry using hematoxylin- and eosin-stained tissue sections.

Authors:  Farzad Fereidouni; Austin Todd; Yuheng Li; Che-Wei Chang; Keith Luong; Avi Rosenberg; Yong-Jae Lee; James W Chan; Alexander Borowsky; Karen Matsukuma; Kuang-Yu Jen; Richard Levenson
Journal:  Biomed Opt Express       Date:  2019-11-26       Impact factor: 3.732

Review 3.  Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy.

Authors:  Elena García-Martínez; Melody Smith; Aitziber Buqué; Fernando Aranda; Francisco Ayala de la Peña; Alejandra Ivars; Manuel Sanchez Cánovas; Ma Angeles Vicente Conesa; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-02-15       Impact factor: 8.110

Review 4.  Mechano-therapeutics: Targeting Mechanical Signaling in Fibrosis and Tumor Stroma.

Authors:  Daniel J Tschumperlin; David Lagares
Journal:  Pharmacol Ther       Date:  2020-05-11       Impact factor: 12.310

5.  Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment.

Authors:  Florence Gazeau; Emmanuel Donnadieu; Alba Nicolas-Boluda; Javier Vaquero; Lene Vimeux; Thomas Guilbert; Sarah Barrin; Chahrazade Kantari-Mimoun; Matteo Ponzo; Gilles Renault; Piotr Deptula; Katarzyna Pogoda; Robert Bucki; Ilaria Cascone; José Courty; Laura Fouassier
Journal:  Elife       Date:  2021-06-09       Impact factor: 8.140

6.  PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma.

Authors:  Xiaochao Tan; Priyam Banerjee; Edward A Pham; Florentine U N Rutaganira; Kaustabh Basu; Neus Bota-Rabassedas; Hou-Fu Guo; Caitlin L Grzeskowiak; Xin Liu; Jiang Yu; Lei Shi; David H Peng; B Leticia Rodriguez; Jiaqi Zhang; Veronica Zheng; Dzifa Y Duose; Luisa M Solis; Barbara Mino; Maria Gabriela Raso; Carmen Behrens; Ignacio I Wistuba; Kenneth L Scott; Mark Smith; Khanh Nguyen; Grace Lam; Ingrid Choong; Abhijit Mazumdar; Jamal L Hill; Don L Gibbons; Powel H Brown; William K Russell; Kevan Shokat; Chad J Creighton; Jeffrey S Glenn; Jonathan M Kurie
Journal:  Sci Transl Med       Date:  2020-01-22       Impact factor: 17.956

7.  Extracellular matrix alterations in low-grade lung adenocarcinoma compared with normal lung tissue by imaging mass spectrometry.

Authors:  Peggi M Angel; Evelyn Bruner; Jennifer Bethard; Cassandra L Clift; Lauren Ball; Richard R Drake; Carol Feghali-Bostwick
Journal:  J Mass Spectrom       Date:  2020-02-21       Impact factor: 1.982

8.  Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity.

Authors:  Neus Bota-Rabassedas; Priyam Banerjee; Yichi Niu; Wenjian Cao; Jiayi Luo; Yuanxin Xi; Xiaochao Tan; Kuanwei Sheng; Young-Ho Ahn; Sieun Lee; Edwin Roger Parra; Jaime Rodriguez-Canales; Jacob Albritton; Michael Weiger; Xin Liu; Hou-Fu Guo; Jiang Yu; B Leticia Rodriguez; Joshua J A Firestone; Barbara Mino; Chad J Creighton; Luisa M Solis; Pamela Villalobos; Maria Gabriela Raso; Daniel W Sazer; Don L Gibbons; William K Russell; Gregory D Longmore; Ignacio I Wistuba; Jing Wang; Harold A Chapman; Jordan S Miller; Chenghang Zong; Jonathan M Kurie
Journal:  Cell Rep       Date:  2021-04-20       Impact factor: 9.423

Review 9.  Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders.

Authors:  Alexandros Marios Sofias; Federica De Lorenzi; Quim Peña; Armin Azadkhah Shalmani; Mihael Vucur; Jiong-Wei Wang; Fabian Kiessling; Yang Shi; Lorena Consolino; Gert Storm; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2021-06-15       Impact factor: 15.470

Review 10.  Stromal Cells Underlining the Paths From Autoimmunity, Inflammation to Cancer With Roles Beyond Structural and Nutritional Support.

Authors:  Amanda M Honan; Zhibin Chen
Journal:  Front Cell Dev Biol       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.